New research shows that inhibiting overactive LRRK2 enzymes could stabilize Parkinson's disease progression, with Stanford ...

A team of researchers has discovered that a protein called cypin plays a powerful role in helping brain cells connect and ...

The results of experiments in mice models were "astounding," said biochemist Suzanne Pfeffer of Stanford University.

The findings of two recent studies give hope that the disease could one day be reversed in humans—but experts warn that this ...

Parkinson's disease is a neurogenerative disease that affects more than 1 million people in the U.S. While some cases are ...

The company completed a clinical trial at nine centers across the U.S., Europe and Asia before it received FDA approval.

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

A groundbreaking advancement by a team of scientists in Australia—led by Indian-origin researchers—could dramatically change ...

A team of neuroscientists in Australia has found that restoring copper levels in the brain dramatically reduced Parkinson-like damage in mice. The approach restored a protein’s function, and the same ...

A new weekly injectable drug could transform the lives of more than eight million people living with Parkinson's disease, ...

Currently dopamine replacement medications, like levodopa and dopamine agonists, are the primary treatment for Parkinson's ...

Sara Penuela Rodriguez (left), an interdisciplinary neuroscience doctoral student, administers infrared laser light therapy ...